Deferoxamine ameliorates adipocyte dysfunction by modulating iron metabolism in ob/ob mice

Objective: The mechanisms underlying obesity and anti-obesity processes have garnered remarkable attention as potential therapeutic targets for obesity-associated metabolic syndromes. Our prior work has shown the healing efficacy of iron reduction therapies for hepatic steatosis in a rodent model of...

全面介紹

書目詳細資料
發表在:Endocrine Connections
Main Authors: Hong-Fa Yan, Zhao-Yu Liu, Zhi-Ang Guan, Chuang Guo
格式: Article
語言:英语
出版: Bioscientifica 2018-04-01
主題:
在線閱讀:http://www.endocrineconnections.com/content/7/4/604.full